These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6779091)

  • 21. [Variation in the infective capacity of cultured forms of Trypanosoma cruzi].
    Segura EL; Engel JC; Katzin VJ; Subías E; de Isola ED; Esteva M; Lammel E; Di Rissio AM; González Cappa SM
    Medicina (B Aires); 1980; 40 Suppl 1():256-7. PubMed ID: 7005611
    [No Abstract]   [Full Text] [Related]  

  • 22. Trypanosoma cruzi and immunoprotection: study of an attenuated strain.
    de Campanini AR; Esteva M; Laguens RP; Segura EL
    Medicina (B Aires); 1982; 42(5):502-6. PubMed ID: 6820463
    [No Abstract]   [Full Text] [Related]  

  • 23. Culturing and biological cloning of Trypanosoma cruzi.
    Miles MA
    Methods Mol Biol; 1993; 21():15-28. PubMed ID: 8220712
    [No Abstract]   [Full Text] [Related]  

  • 24. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
    Rowland E; Luo H; McCormick T
    J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation of a Trypanosoma cruzi strain of predominantly slender form in Argentina].
    González Cappa SM; Bijovsky AT; Freilij H; Muller L; Katzin AM
    Medicina (B Aires); 1981; 41(1):119-20. PubMed ID: 6790898
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver.
    Scott MT; Moyes L
    Clin Exp Immunol; 1982 Jun; 48(3):754-7. PubMed ID: 6811174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological properties of Trypanosoma cruzi metacyclic trypomastigotes: usefulness for studying Chagas' disease (brief report).
    Contreras VT; Araque WH; Delgado VS
    Biol Res; 1993; 26(1-2):315-6. PubMed ID: 7670544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Where do we stand on the autoimmunity hypothesis of Chagas disease?
    Kierszenbaum F
    Trends Parasitol; 2005 Nov; 21(11):513-6. PubMed ID: 16125464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma cruzi: infectivity modulation of a clone after passages through different hosts.
    Pérez Brandán C; Padilla AM; Diosque P; Basombrío MA
    Exp Parasitol; 2006 Oct; 114(2):89-93. PubMed ID: 16564526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of RNA and DNA from Trypanosoma cruzi.
    Ashall F
    Methods Mol Biol; 1993; 21():113-22. PubMed ID: 8106094
    [No Abstract]   [Full Text] [Related]  

  • 32. Culture medium for a continuous source of Trypanosoma cruzi metacyclic forms.
    de Isola EL; Lammel EM; Muller LA; Cappa SM
    J Parasitol; 1987 Apr; 73(2):441-3. PubMed ID: 3108481
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease.
    Añez N; Crisante G; da Silva FM; Rojas A; Carrasco H; Umezawa ES; Stolf AM; Ramírez JL; Teixeira MM
    Trop Med Int Health; 2004 Dec; 9(12):1319-26. PubMed ID: 15598264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrastructural investigations on the effect of cyclophosphamide on experimental Trypanosoma cruzi infections (author's transl)].
    Hüther AM
    Tropenmed Parasitol; 1981 Mar; 32(1):51-4. PubMed ID: 6785913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
    Campos MA; Gazzinelli RT
    Mediators Inflamm; 2004 Jun; 13(3):139-43. PubMed ID: 15223603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian cellular culture models of Trypanosoma cruzi infection: a review of the published literature.
    Duran-Rehbein GA; Vargas-Zambrano JC; Cuéllar A; Puerta CJ; Gonzalez JM
    Parasite; 2014; 21():38. PubMed ID: 25083732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological and morphometric variability of three clones of Trypanosoma cruzi and the strain of origin (Bolivia).
    Penín P; Gamallo C; González M; De Diego JA
    Medicina (B Aires); 1997; 57(5):571-80. PubMed ID: 9674226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Chagas disease in the mouse: III. Absence of concomitant immunity after repeated infections.
    Cabeza Meckert P; Laguens RP
    Medicina (B Aires); 1981; 41(5):543-8. PubMed ID: 6808284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.